Tag Archives: Lubrizol

Lubrizol Signs Agreement with Finolex Industries for CPVC Pipe in India

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation, inventors and the largest manufacturers of CPVC compound worldwide, and Finolex Industries Limited, the leading PVC pipes and fittings manufacturer in India,have announce the signing of, FlowGuard® Processor agreement for the manufacturing and sale of Finolex FlowGuard®Plus pipes and fittings in India.

In August, 2016, Lubrizol terminated its processor agreements with Astral Poly-Technik Limited for the manufacture and sale of FlowGuard®, BlazeMaster® and Corzan® branded pipes and fittings in India.

Under the new agreement, Finolex Industries will begin marketing in the last week of March 2017, and will cater to the building and construction industry.

“Lubrizol is dedicated to supplying the highest quality CPVC compounds to service the Indian hot & cold water plumbing markets,” explains Matthew Timmons, managing director, Lubrizol Advanced Materials India Pvt. Ltd. “Our partnership with Finolex Industries highlights the need and importance of quality CPVC pipes and fittings made from time-tested CPVC compounds provided by Lubrizol. Since January 2016, we have been manufacturing these world quality materials from a state-of-the art plant in Dahej, Gujarat. Our association with Finolex will further strengthen FlowGuard’s commitment to delivering reliability in India through Finolex’s wide spread network in the country.”

Timmons continues, “Since we introduced FlowGuard to the Indian market, we remained committed through our support of processors who continue to benefit from our more than 50 years of expertise in manufacturing and compounding. Additionally, with the government’s recent focus on housing for all, the infrastructure status given to real estate, loans offered at cheaper rates, introduction of the Real Estate Regulatory Act (RERA), GST & many other initiatives, the need for quality products to be used in the country is greater than ever.”

Lubrizol introduced the resilient CPVC material into India nearly two decades ago. Since then, India’s plumbers, engineers, builders and consultants have been reassured by the only material of its kind to be designed and approved to meet all global standards.

Prakash Chhabria, executive chairman of Finolex Industries Limited expressed his views on the special occasion, saying, “We are committed to strengthening the plumbing industry through our association with Lubrizol falls in line with the culture of Finolex Industries in providing quality products ‘Made in India’ for the Indian market. We are confident about Lubrizol’s global expertise in compounding and appreciate the work done by them in changing the plumbing industry from metal-based to CPVC–based piping. With FlowGuard’s raw material and support, our track record of providing superior products for Indian market gets strengthened. We look forward to a successful partnership.”
industry and we are honored they have chosen to take advantage of our industry-leading cold chain network, expanded fresh foods program and award-winning category management expertise. We are proud to partner with such a strong leader within our industry and look forward to building the foundation for a long lasting and mutually successful relationship.”

© 2017 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized

Lubrizol LifeSciences Announces New Compounding Capabilities

(BRK.A), (BRK.B)

The Lubrizol Corporation’s LifeSciences (LLS) business has announced the addition of compounding capabilities for its Pellethane® and Isoplast® products for medical device customers.

The new offering enables LLS to provide color matching, radiopacity and custom compound development services and complements LifeSciences’ existing polymer portfolio, formulation and manufacturing capabilities to enable success for medical device customers.

As part of this new service, LLS provides custom color matching for brand recognition, safe identification and aesthetics in medical device applications. Since pigment requirements are ever changing, LifeSciences pays close attention to ensure that colorants meet applicable regulatory requirements.

Along with color matching, LLS also offers radiopaque materials for X-ray identification and proper device positioning; critical for patient safety and comfort. Pellethane and Isoplast compounds with barium sulfate and tungsten are now both available from LLS.

Pellethane thermoplastic polyurethane is available as aromatic polyethers or polyesters and are known for their flexibility and wide range of hardness. Pellethane TPUs are excellent for a variety of medical applications including tubing, catheters and other short-term uses.

Isoplast engineered thermoplastic polyurethanes are designed for rigid polymer requirements due to their high tensile strength and impact resistance. Isoplast medical polymers may be used to replace polycarbonate where stress cracking is an issue or coloring is difficult. Isoplast is ideal for applications needing an impact resistance-based polymer.

This new capability is made possible through a partnership with trusted custom medical plastics compounder, Compounding Solutions. Compounding Solutions is committed to manufacturing specialty plastics compounds and concentrates of the highest quality in order to satisfy requirements of the medical device industry.

© 2017 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Consolidates Skin Care Units Under Lipotec USA Banner

(BRK.A), (BRK.B)

Berkshire Hathaway’s Specialty chemicals company Lubrizol is consolidating its Active Organics and Lipotec skin care units, and giving them a new name, Lipotec USA.

In 2011, Lubrizol acquired Active Organics, a manufacturer and supplier of naturally-derived specialty ingredients including botanical extracts and natural performance ingredients for the personal care industry.

The following year, Lubrizol acquired Lipotec SA, a leader in the development, manufacturing and sale of personal care ingredients based on three core technologies: peptide-based active cosmetic ingredients, delivery systems and biotechnology products.

Lipotec USA, Inc. will be located at the current address of Active Organics, Inc. in Lewisville, Texas.

© 2017 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Gets Tax Abatement Extension to Expand Wickliffe Headquarters

(BRK.A), (BRK.B)

The Wickliffe, Ohio City Council has approved the extension of the 10-year, 50 percent tax abatement enterprise zone that was originally granted to Berkshire Hathaway’s Lubrizol Corporation in 2014. The extension means the tax abatement will now be available to Lubrizol until 2029.

The Council had given the mayor permission to extend the agreement at its December 16, 2016 meeting.

Lubrizol is planning to commence construction in 2018 on a 63,000-square-foot, single-story multi-purpose facility at its current Lakeland Boulevard headquarters. The extension will serve to connect two of its existing buildings.

Acquired by Berkshire Hathaway for $9 billion in cash in 2011, specialty-chemicals-maker Lubrizol owns and operates manufacturing facilities in 17 countries.

© 2017 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Has New President

(BRK.A), (BRK.B)

Berkshire Hathaway’s wholly-owned specialty chemical company, Lubrizol Corp., has appointed a new CEO, effective Jan. 2, 2017.

Eric R. Schnur has taken on the role of chairman, president and CEO as part of a planned leadership transition announced in mid-2016. Schnur succeeds James L. Hambrick, who had been serving as chairman and CEO.

Schnur was named president and chief operating officer of Lubrizol on June 1, 2016, the company’s release stated. Prior to that, he had served as president of the company’s Advanced Materials business segment. In total, he has been with Lubrizol for more than 27 years, having joined it as an engineer in research and development. He has a bachelor of science degree in chemical engineering from Pennsylvania State University and an MBA from Case Western Reserve University.

© 2017 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Launches Lubricant Market Advocacy Website

(BRK.A), (BRK.B)

The Lubrizol Corporation’s Lubrizol Additives business segment has launched a new, all-encompassing industry insight website, LubrizolAdditives360.com.

The website serves as a convenient single source for content that covers the entire lubricant market and reinforces Lubrizol’s role as a market leader in the industry.

The new site incorporates all the information and insights customers have come to rely on from Lubrizol’s previous industry insight websites, DriveLineNEWS.com, FluidLineFlash.com, GF-¬6.com, HDDEO.com, MCEO.com and PCEO.com. Content on the site is arranged in a format that aligns with the following specific business focus areas and the correlating opportunities in the marketplace:

• Passenger (including passenger car and motorcycle)
• Commercial (including on-road and off-road vehicles)

Key features of LubrizolAdditives360.com include:

• announcements on the latest engine oil specifications;
• information on advancements in passenger vehicle technology;
• reports on new trends in automotive gear manufacturing;
• intelligence on driveline and engine oil lubricants and fuels; and
• insight into innovative solutions for off-highway vehicles.

“Lubrizol Additives has always taken great pride in being a market leader and an advocate for the use of higher performing lubricants,” said Mike McCabe, director, Lubrizol Additives global marketing. “We are confident that this new industry insight website will provide valuable content for our customers and continue to drive the industry forward in a positive direction.”

© 2016 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol to Benefit From Robust Market for Medical Tubing

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol will benefit from the robust growth projected to come from the medical tubing market over the next five years.

Analysts at Research and Markets are projecting a compound annual growth rate (CAGR) of 8.0% from 2016 to reach a total market size of USD $5.85 Billion, by 2021.

In 2014, Lubrizol acquired Vesta Inc., a maker of catheters and tubing based on silicone and thermoplastics.

According to Research and Markets, the market is mainly driven by minimally invasive surgery.

Another major factor that is expected to bring momentum to this market are increasing aging population, especially in developing countries, and the rising awareness about healthcare and the government initiatives to improve the quality of the healthcare infrastructure.

Silicone and TPE & TPE are expected to register high CAGRs between 2016 and 2021, in terms of volume. Silicone and other specialty polymers are replacing PVC due to their sterilization capabilities and microwave property, which PVC cannot sustain.

North America accounted for the largest share of the global medical tubing market and is projected to continue dominating the market during the forecast period while Asia-Pacific is projected to witness the highest CAGR during the forecast period due to the improving lifestyles of the population in the region. North America accounted for the largest share in 2015 in the medical tubing market due to focused interest of its government to provide quality healthcare facilities.

Bulk disposable tubing application is projected to account for highest market share during the forecast period. Medical tubing is widely used in the bulk disposable and dialysis applications. Bulk disposable tubing is used in blood bags used for blood transfusion, intravenous infusion tubing, drug delivery disposables, respiratory disposables, products for dialysis, laboratory disposables, wound management disposables, nonwoven medical disposables, sterilization supplies, waste disposable supplies, and others, such as diagnostic disposables. These disposable tubings are used mainly in hospitals.

Medical tubing manufactured from polymers is preferred because of their favorable properties such as resistance to sterilization condition, flexibility, inertness to body tissues & fluids.

Significant investment and the time required for product development act as a major restraint in the medical tubing market. In order to develop new and innovative products, technologies, and manufacturing processes, the market players collaborate with each other. These collaborations are expected to overcome this restraint during the forecast period.

At the time of the Vesta acquisition, Lubrizol’s Deb Langer stated that “the addition of Vesta significantly enhances our life science offerings through the combination of strong polymer technology, applications know-how and world class component manufacturing.”

© 2016 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Announces Distribution Partnership with LEHVOSS

(BRK.A), (BRK.B)

The Lubrizol Corporation’s` Advanced Materials business has announced a new distribution partnership with LEHVOSS Italia S.r.l. covering Italy, for Lubrizol`s PearlbondTM TPU (thermoplastic polyurethane) for reactive hot melts (HMPUR or RHM) and shoe stiffeners, and PearlstickTM TPU for solvent-based adhesives.

LEHVOSS Italia S.r.l. is the affiliated company in Italy of Lehmann & Voss & Co., which has been selling chemical specialties for the industrial sector for more than 120 years.

LEHVOSS is a well-established distributor of chemical specialities for diverse industries, such as: plastics, adhesives, compounds and polyester resins, rubber, paints, coatings and polyurethane polymers.

Javier Tortosa, Lubrizol Engineered Polymers global adhesives business manager, comments, “With this agreement we are looking forward to expanding the growth of our specialty TPU solutions in the Italian adhesive market and delivering consistently excellent service to new customers. We expect to provide high-value, differentiated technology solutions through this partnership with LEHVOSS in Italy.”

Lubrizol`s Pearlstick and Pearlbond TPU product lines include TPU specialties used as additives to increase HMPUR crystallization speed and green strength, as well as improve adhesion to substrates, accelerate setting and open times, by applying them in the following industries and applications: transportation (component bonding), technical textiles and furniture (edge banding, profile wrapping).

© 2016 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol’s Particle Sciences Signs Deal with Glenmark for Cancer Drug

(BRK.A), (BRK.B)

Particle Sciences, a division of Berkshire Hathaway’s Lubrizol, has signed a deal with Glenmark Pharmaceuticals for the development and marketing of a generic version of the cancer drug Abraxane.

A Glenmark press release stated “The company has entered into a strategic development, license and commercialisation agreement with Particle Sciences Inc to develop and market a generic version of Celgene’s Abraxane product – paclitaxel protein (albumin)-bound particles for injectable suspension.”

Particle Sciences will develop the product exclusively for Glenmark, which is making a generic version of Celgene’s Abraxane, a drug that had worldwide sales in 2015 of $967 million.

Abraxane is prescribed for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.

“The partnership is a significant development in Glenmark’s complex generics strategy and we are pleased to collaborate with Particle Sciences given their strong technical capabilities and understanding of particulate injection products. This is a challenging product to develop and we expect it to remain a limited competition opportunity,” said Glenmark Pharmaceuticals’ Robert Matsuk, president – North America and global API.

Under the terms of the agreement, Particle Sciences will receive milestone payments during various stages of the product’s development from Glenmark, including royalties on sales.

About Particle Sciences

Acquired by The Lubrizol Corporation in 2015, Particle Sciences is a leading contract drug development and manufacturing organization with a comprehensive suite of services for the formulation, analysis and production of complex drug delivery solutions.

© 2016 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Terminates Agreements with Astral Poly-Technik

(BRK.A), (BRK.B)

The Lubrizol Corporation has terminated its processor agreements with Astral Poly-Technik Limited for the manufacture and sale of FlowGuard®, BlazeMaster® and Corzan® branded pipes and fittings in India.

Lubrizol, which is the inventor of chlorinated polyvinyl chloride (CPVC), is known in India amongst the engineers, builders, constructors and plumbers for its globally approved and certified CPVC compounds used in pipes for plumbing, fire protection and industrial applications.

The move comes out of Astral Poly-Technik Ltd’s recent decision to begin local compounding of material and launch house branded lines of chlorinated polyvinyl chloride (CPVC), which is in conflict with Lubrizol’s long established and successful CPVC branded business model.

With termination of this partnership, starting from October 9, 2016, Astral will no longer have access to Lubrizol’s compound or manufacturing assistance, and will no longer be permitted to sell FlowGuard, BlazeMaster or Corzan branded pipes and fittings.

Lubrizol, the owner of the trademarks, will continue to make its CPVC brands and products available in wide distribution throughout India from other Lubrizol contracted partners.

Commenting on the termination of partnership with Astral Poly-Technik Limited, Mathew Timmons, Managing Director, Lubrizol Advanced Materials India Pvt. Ltd. said, “Lubrizol is dedicated to supplying the highest quality CPVC products to service the Indian market. Our commitment remains steadfast through our support of processors like Ashirvad Pipes Pvt. Ltd. who continue to benefit from our more than 50 years of expertise in compounding and manufacturing CPVC.”

Lubrizol in India

In February 2016, Lubrizol Corporation, a wholly-owned subsidiary of Berkshire Hathaway, opened a chlorinated polyvinyl chloride (CPVC) compounding plant in Dahej, India. Lubrizol invested $50 million U.S. (INR 325 CR) in the plant, which has a capacity to produce approximately 55,000 metric tons of compounds annually.

© 2016 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.